David A. Siegel Harrow Health, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 29,300 shares of HROW stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,300
Previous 57,800
49.31%
Holding current value
$1 Million
Previous $1.21 Million
9.11%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$137 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$74 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$73.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$63.9 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$25 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $926M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...